How to control highly endemic hepatitis B in Asia

Abstract

Chronic hepatitis B virus (HBV) infection is an enormous economic and social burden. Asian countries such as Vietnam, Mongolia, Laos, China, the Philippines, South Korea, Singapore and Cambodia have high or high‐intermediate HBsAg prevalence. Most of the chronic HBV carriers in this region acquire their infection during early childhood or through mother‐to‐child transmission (MTCT). Asia has been highly successful in controlling HBV in the last 2 decades. For example, China has adopted a comprehensive strategy to control HBV and has offered universal HBV vaccination to infants since 1992. With increasing coverage and a timely birth dose of the HBV vaccine, the prevalence of HBsAg in that general population decreased from 9.75% in 1992 to 7.18% in 2006. The prevalence of HBsAg in the population

 

KEYWORDS
Asia, China, control, hepatitis B virus, prevention, vaccine

 

About Speaker

Jidong JIA

Professor of Medicine & Director, Liver Research Center

China

City: Beijing

Institution: Beijing Friendship Hospital, Capital Medical University

Contact: jia_jd@ccmu.edu.cn


Biography of Jidong JIA

He received his doctor;s degree from Capital Medical University, Beijing China and finished his postdoctorial training at Klinikum Benjamin Franklin, Free University of Berlin, Germany. His clinical interests include the chronic viral hepatitis, autoimmune and cholestatic liver diseases. His main research work includes the pathogenesis and treatment of l liver fibrosis.

 

He is the President-Elect of IAS, Past President of APASL (2009-2010) and Immediate Past President of the Chinese Society of Hepatology. He currently serves China Foundation of Viral Hepatitis Prevention and Control as vice president, and CEVHAP as Executive Council Member. He also serves as associate editor for Journal of Gastroenterology & Hepatology and Hepatology International.

View more